If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 580.00
Bid: 578.00
Ask: 580.00
Change: -10.00 (-1.69%)
Spread: 2.00 (0.346%)
Open: 589.00
High: 589.00
Low: 578.00
Prev. Close: 590.00
BAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

1 Feb 2024 07:00

RNS Number : 6024B
Barr(A.G.) PLC
01 February 2024
 

IMMEDIATE RELEASE 1 February 2024

A.G. BARR p.l.c.

("A.G. BARR" or "the Group")

Trading Update

 

A.G. BARR p.l.c., the branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.

 

Strong revenue and profit performance - positive business momentum

We are pleased to report an anticipated strong revenue and profit performance in respect of the full year ended 28 January 2024.

52 weeks ended28 January 2024

52 weeks ended29 January 2023

Growth

Group revenue

c.£400m

£317.6m

c.26%

 

Revenue is expected to be c.£400m, representing c.26% year-on-year growth and c.7.6% on a like-for-like basis, excluding the contribution from the Boost Drinks business acquired in December 2022. 

Adjusted profit before tax1 is now expected to be c.£49.5m, up 13.8% on the prior year (2022/23 : £43.5m) and slightly ahead of previous market expectations.

Despite the wet summer weather which impacted Q3 market conditions, our positive underlying brand momentum ensured a strong H2 Group performance :

? Soft Drinks - including IRN-BRU, Rubicon and Boost

Inflation in the wider soft drinks market continued to drive value growth but impacted volumes within the sector. However, our brand building and pricing strategy delivered both value and volume growth, ensuring we continue to offer consumers great tasting and affordable brands.

? FUNKIN Cocktails

Delivered a strong Q4 particularly in the off trade through an excellent performance in the ready to drink segment. While the on trade channel remains variable, with late night venues experiencing reduced footfall, reports of improved festive trading for a range of hospitality venues is encouraging as we look forward.

? MOMA Foods  

Further double-digit sales growth, supported by new business wins, most notably within the speciality coffee channel.

We continue to experience cost inflation albeit at a less significant level than in the prior year. Our supply chain capital investment programme is on track supporting the in-sourcing of the Boost and Rio brands. The associated operational leverage and synergy benefits are supporting the acceleration of our margin rebuild programme.

Roger White, Chief Executive, commented :

"All our teams across the Group have worked hard to deliver an excellent overall performance. This has been supported by continued brand investment, strong execution of our sales plans and progress across our supply chain improvement programme. We have positive momentum behind our brands and business as we enter the new financial year.

This strong trading performance, coupled with the benefits already being delivered by our margin rebuild programme, has ensured we close the year with a strong profit performance and confidence in the Group's long-term growth strategy."

For more information, please contact :

A.G. BARR Instinctif Partners

0330 390 3900 020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Full Year Results - 26 March 2024

 

Note 1 : Reported profit before tax is currently expected to be c.£50.3m reflecting the release of a £0.8m prior year accrual associated with the acquisition earn-out of Boost Drinks Limited in December 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPURAGUPCGMG
Date   Source Headline
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update
28th Mar 20237:00 amRNSFinal results for the year ended 29 January 2023
8th Mar 202310:57 amRNSDirector/PDMR Shareholding
8th Feb 202311:09 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
27th Jan 20232:39 pmRNSNotice of Trading Update
10th Jan 20232:01 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition of MOMA minority shareholding
14th Dec 20226:00 pmRNSContourGlobal
8th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition of Boost Drinks Holdings Limited
8th Nov 202210:41 amRNSDirector/PDMR Shareholding
1st Nov 20222:38 pmRNSDirector/PDMR Shareholding
1st Nov 20222:34 pmRNSDirector/PDMR Shareholding
1st Nov 20222:30 pmRNSDirector/PDMR Shareholding
25th Oct 20229:34 amRNSDirectorship
10th Oct 20221:44 pmRNSDirector/PDMR Shareholding
27th Sep 20227:05 amRNSUpdate statement on 2022 AGM Voting Results
27th Sep 20227:00 amRNSInterim Results
12th Sep 20223:18 pmRNSHolding(s) in Company
8th Sep 20222:08 pmRNSDirector/PDMR Shareholding
31st Aug 202210:29 amRNSNotice of Interim Results Date
8th Aug 20221:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSTrading Update
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.